TRU

• Net income attributable to TransUnion was $143 million, with diluted EPS of $0.74, compared to $110 million and $0.56 in Q2 2025.
• Adjusted EBITDA was $456 million, up 12% (7% organic constant currency), with margin of 34.8%.
• The company raised full-year 2026 guidance, expecting revenue growth of 12% to 13% (8% to 9% organic constant currency).
• Year-to-date share repurchases totaled approximately $150 million through July.

2.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits

• TransUnion held its Annual Meeting of Stockholders on May 12, 2026.
• Stockholders ratified PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.
• Non-binding advisory vote approved named executive officer compensation.
• Advisory stockholder proposal for right to call a special meeting was approved.

5.07 Submission of Matters to a Vote of Security Holders · 9.01 Financial Statements and Exhibits

• Net income attributable to TransUnion was $397 million, compared with $148 million in Q1 2025, including a $225 million gain on the previously held equity interest in Trans Union de Mexico.
• Adjusted EBITDA was $438 million, up 10% (9% constant currency, 7% organic constant currency) from $397 million in Q1 2025; Adjusted EBITDA margin was 35.2% versus 36.2%.
• Adjusted Diluted EPS was $1.18, up from $1.05 in Q1 2025; Diluted EPS was $2.04 versus $0.75.
• The company raised full-year 2026 guidance: revenue $5,100-$5,135 million, Adjusted EBITDA $1,796-$1,816 million, Adjusted Diluted EPS $4.68-$4.75.

2.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure

• The company reintroduced a medium-term financial framework targeting high-single digit organic constant-currency revenue growth per year, 50 basis points of underlying Adjusted EBITDA margin expansion per year, and low-to-mid teens Adjusted Diluted EPS growth per year.
• TransUnion reiterated its full-year 2026 financial guidance previously released on February 12, 2026, which does not include the acquisition of majority ownership of Trans Union de México, S.A., S.I.C., closed on March 2, 2026.
• The company expects to incorporate the Trans Union de México acquisition into its full-year 2026 guidance alongside its first quarter 2026 earnings results.
• TransUnion re-confirmed its expectation to deliver 90 percent or greater free cash flow conversion over the medium term and anticipates an increased bias to return capital to shareholders through share repurchases and dividends.

7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits

• Q4 2025 revenue was $1,171 million, up 13% (12% organic constant currency) from Q4 2024.
• Q4 2025 net income attributable to TransUnion was $101 million, up from $66 million in Q4 2024; diluted EPS was $0.52.
• Full-year 2025 revenue was $4,576 million, up 9% (10% constant currency); adjusted EBITDA was $1,646 million.
• Company introduced 2026 guidance: revenue growth of 8-9% and adjusted diluted EPS growth of 8-10%.
• Board declared a quarterly dividend of $0.125 per share, payable March 13, 2026.

1.01 Entry into a Material Definitive Agreement · 2.02 Results of Operations and Financial Condition · 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits

• Sayan Chakraborty and Charlotte B. Yarkoni were appointed as directors effective January 5, 2026, to fill the newly created directorships.
• Both will serve for the balance of the term expiring at the 2026 annual meeting of stockholders.
• Chakraborty will serve on the Technology Committee; Yarkoni will serve on the Compensation Committee.
• They will be compensated under TransUnion's standard policies for non-employee independent directors; no arrangements or reportable transactions were disclosed.

5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 9.01 Financial Statements and Exhibits

• Total revenue for Q3 2025 was $1,170 million, an 8% increase from Q3 2024.
• Adjusted EBITDA was $425 million, up 8% from $394 million; margin was 36.3%, flat year-over-year.
• Company raised 2025 revenue growth guidance to 8-8.5% as reported.
• Share repurchases totaled $160 million in Q3 and October, bringing year-to-date to $200 million; authorization increased to $1 billion.

2.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits

• Total revenue for Q2 2025 was $1,140 million, a 10% increase (9% organic constant currency) compared to Q2 2024.
• Adjusted EBITDA was $407 million, up 8% from $377 million in Q2 2024; adjusted EBITDA margin was 35.7%.
• The company raised 2025 guidance, expecting 6-7% revenue growth on both reported and organic constant currency basis.
• Leverage ratio was 2.8x at quarter-end, and the company repurchased $47 million of shares through mid-July.

2.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits